News

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the ...
As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain. New variants of the virus will likely emerge, driven by positive selection for traits such as increased ...
Researchers used the platform to analyze over 10 billion potential antibody modifications and predict which alterations would enhance binding to SARS-CoV-2 variants, including those not yet in ...
A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could ...
As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain. New variants of the virus will likely emerge, driven by positive selection for traits such as increased ...
Quantum mechanical modeling allowed the team to develop an initial set of predictions about the role of mutations on infectivity and immune response evasion of Omicron and other SARS-CoV-2 variants ...
Researchers have developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially ...
GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ATLANTA, GA - ...
Researchers used the platform to analyze over 10 billion potential antibody modifications and predict which alterations would enhance binding to SARS-CoV-2 variants, including those not yet in ...
Patients with cardiac symptoms had higher scores on the PHQ-2 and GAD-2 and higher percentages of responses indicating ...